Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

DAIICHI S : Notice on Details of the Share Options

07/12/2011 | 04:20am US/Eastern
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126 on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)


Date of Board of Directors resolution: June 27, 2011

Recommend :
React to this article
3d ago DAIICHI SANKYO : Initiation of Phase 3 Trial of CHS-0214 (Investigational Etaner..
3d ago RANBAXY LABORATORIES : Talks on to get competition panel nod for ranbaxy deal: s..
4d ago DAIICHI SANKYO : Initiation of Phase 3 Trial of CHS-0214 (Investigational Etaner..
6d ago Sun's Ranbaxy deal on course, hints at more
08/14 Sun Pharma reports a strong quarter
08/13 DAIICHI SANKYO : and Charleston Laboratories Announce Collaboration to Develop a..
08/12 Ranbaxy brands to stay alive
08/12 Sun plans to rise in japan's pharma market
08/11 Sun-ranbaxy deal an acid test for competition regulator
08/11 Sun- Ranbaxy deal comes under CCI lens
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Income Statement Evolution
DAIICHI SANKYO COMPANY, LI : Income Statement Evolution
More Financials
Dynamic quotes